Menu
Recruiting NCT06934499

Tunisian Lung Cancer Study

— Observational Pulmonary Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Pulmonary Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Tunisia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Clinical Observational Study on Tunisian Lung Cancer

Overview

This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.

Primary outcome measures

  • Diagnostic delay [Time frame: Day 1]
  • Survival [Time frame: 12 months]
  • Relapse [Time frame: 12 months]
Secondary outcome measures (1)
  • Recommendation Compliance [Time frame: Day 1]

Eligibility criteria

Inclusion criteria

  • Age more than 18 years
  • Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date
  • Informed consent

Exclusion criteria

  • None

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Tunisia · 2 centers
  • Tunisian Society of Medical Oncology — Aryanah
  • Tunisian Society of Respiratory Diseases and Allergology — Tunis

Identifiers

NCT: NCT06934499 · DAC-01-LUNGTUN

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗